Patient experience in a rare disease: application of the IEXPAC questionnaire in hereditary transthyretin-mediated amyloidosis
- 3 June 2021
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Orphan Drugs
- Vol. 9 (6) , 175-180
Abstract
Background: Hereditary transthyretin amyloidosis (hATTR amyloidosis) is a rare, disabling and potentially fatal disease. The purpose of this investigation was to analyze the experience reported by hATTR amyloidosis population and develop a strategy to improve results for patients searching Internet for knowledge about their disease. Methods: A cross-sectional study, including adult hATTR amyloidosis patients with active treatment managed at a secondary hospital, was conducted during 2020. The study was carried out in two phases: first, the patient’s experience was analyzed through the IEXPAC questionnaire; second, an intervention was carried out to improve the worst-valued indicators. Results: The survey was conducted on 15 patients. The mean ± SD IEXPAC score was 3.8 ± 0.9. The best scores were those directed to the care offered by healthcare professionals. The worst scores were for obtaining information on Internet and use of the mobile phone to consult medical records. The application of the IEXPAC questionnaire resulted in the production of informative material. Conclusion: This is the first investigation that applies the IEXPAC questionnaire to patients with hATTR amyloidosis. This study supplies useful finding that may be used in future investigations to address hATTR amyloidosis patients’ needs and challenges on the way to patient-centered care.Keywords
This publication has 17 references indexed in Scilit:
- Measuring what matters to rare disease patients – reflections on the work by the IRDiRC taskforce on patient-centered outcome measuresOrphanet Journal of Rare Diseases, 2017
- Rare Diseases on the Internet: An Assessment of the Quality of Online InformationJournal of Medical Internet Research, 2017
- Development and Validation of an Instrument for Assessing Patient Experience of Chronic Illness CareInternational Journal of Integrated Care, 2016
- Living With and Treating Rare DiseasesQualitative Health Research, 2015
- Patient-Reported Outcomes in Clinical Trials of Rare DiseasesJournal of General Internal Medicine, 2014
- Novel Drugs Targeting Transthyretin AmyloidosisCurrent Heart Failure Reports, 2014
- A systematic review of evidence on the links between patient experience and clinical safety and effectivenessBMJ Open, 2013
- Patient-centeredness in PD care: Development and validation of a patient experience questionnaireParkinsonism & Related Disorders, 2012
- Use and Perceived Credibility of Medication Information Sources for Patients with a Rare Illness: Differences by GenderJournal of Health Communication, 2011
- Transthyretin-Related Familial Amyloidotic PolyneuropathyArchives of Neurology, 2005